Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8.

M Hecht; AO Gostian; M Eckstein; S Rutzner; J von der Grün; T Illmer; MG Hautmann; G Klautke; S Laban; Thomas Baptist Brunner; A Hinke; I Becker; B Frey; S Semrau; CI Geppert; A Hartmann; P Balermpas; W Budach; US Gaipl; H Iro; R Fietkau

doi:10.1136/jitc-2020-001378

Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8.

M Hecht
, AO Gostian
, M Eckstein
, S Rutzner
, J von der Grün
, T Illmer
, MG Hautmann
, G Klautke
, S Laban
, Thomas Baptist Brunner
, A Hinke
, I Becker
, B Frey
, S Semrau
, CI Geppert
, A Hartmann
, P Balermpas
, W Budach
, US Gaipl
, H Iro

R Fietkau

Publikation: Beitrag in Fachzeitschrift › Originalarbeit

68 Quellenangaben (Web of Science)

Originalsprache	Englisch
Fachzeitschrift	Journal for ImmunoTherapy of Cancer
DOIs	https://doi.org/10.1136/jitc-2020-001378
Publikationsstatus	Veröffentlicht - 2020

Wissenschaftszweige

301 Medizinisch-theoretische Wissenschaften, Pharmazie
302 Klinische Medizin

Zugriff auf Dokument

10.1136/jitc-2020-001378

Andere Dateien und Links

Dieses zitieren

Hecht, M., Gostian, AO., Eckstein, M., Rutzner, S., von der Grün, J., Illmer, T., Hautmann, MG., Klautke, G., Laban, S., Brunner, T. B., Hinke, A., Becker, I., Frey, B., Semrau, S., Geppert, CI., Hartmann, A., Balermpas, P., Budach, W., Gaipl, US., ... Fietkau, R. (2020). Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2020-001378

@article{f61d368de8164003baad5b18a3b09f1a,

title = "Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8.",

author = "M Hecht and AO Gostian and M Eckstein and S Rutzner and \{von der Gr{\"u}n\}, J and T Illmer and MG Hautmann and G Klautke and S Laban and Brunner, \{Thomas Baptist\} and A Hinke and I Becker and B Frey and S Semrau and CI Geppert and A Hartmann and P Balermpas and W Budach and US Gaipl and H Iro and R Fietkau",

year = "2020",

doi = "10.1136/jitc-2020-001378",

language = "English",

journal = "Journal for ImmunoTherapy of Cancer",

issn = "2051-1426",

publisher = "BMJ Publishing Group",

}

Hecht, M, Gostian, AO, Eckstein, M, Rutzner, S, von der Grün, J, Illmer, T, Hautmann, MG, Klautke, G, Laban, S, Brunner, TB, Hinke, A, Becker, I, Frey, B, Semrau, S, Geppert, CI, Hartmann, A, Balermpas, P, Budach, W, Gaipl, US, Iro, H & Fietkau, R 2020, 'Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8.', Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2020-001378

TY - JOUR

T1 - Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8.

AU - Hecht, M

AU - Gostian, AO

AU - Eckstein, M

AU - Rutzner, S

AU - von der Grün, J

AU - Illmer, T

AU - Hautmann, MG

AU - Klautke, G

AU - Laban, S

AU - Brunner, Thomas Baptist

AU - Hinke, A

AU - Becker, I

AU - Frey, B

AU - Semrau, S

AU - Geppert, CI

AU - Hartmann, A

AU - Balermpas, P

AU - Budach, W

AU - Gaipl, US

AU - Iro, H

AU - Fietkau, R

PY - 2020

Y1 - 2020

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000582120600002

UR - https://pubmed.ncbi.nlm.nih.gov/33023982

UR - https://pmc.ncbi.nlm.nih.gov/articles/PMC7539609

U2 - 10.1136/jitc-2020-001378

DO - 10.1136/jitc-2020-001378

M3 - Research article

C2 - 33023982

SN - 2051-1426

JO - Journal for ImmunoTherapy of Cancer

JF - Journal for ImmunoTherapy of Cancer

ER -